Advanced Bio/Chem Licenses Breast Cancer Biomarker Technology from M.D. Anderson

Mar 16, 2004

NEW YORK, March 16 (GenomeWeb News) - Advanced Bio/Chem has licensed breast cancer protein biomarker technology from the University of Texas' M.D. Anderson Cancer Center, the company said today.

ProteEx, located in The Woodlands, Texas, is doing business as Advanced Bio/Chem.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Prize for Five

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Sure, Blame the Test

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

This Week in Genome Research

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Low Down Syndrome Rates in Iceland

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.

Main menu